Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shoichi Fukui, Ph.D., M.D.

Concepts (369)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Shoichi Fukui's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Shoichi Fukui has written about over time.
Takayasu Arteritis, 5 publications between 2015 and 2019, average publication date November 2016. Giant Cell Arteritis, 3 publications between 2015 and 2019, average publication date February 2017. Synovitis, 5 publications between 2015 and 2019, average publication date March 2017. Prednisolone, 7 publications between 2014 and 2019, average publication date June 2017. Antirheumatic Agents, 10 publications between 2016 and 2020, average publication date August 2017. HTLV-I Infections, 2 publications between 2017 and 2018, average publication date October 2017. Arthritis, Rheumatoid, 15 publications between 2016 and 2021, average publication date December 2017. Cyclophosphamide, 8 publications between 2014 and 2018, average publication date December 2017. Lupus Erythematosus, Systemic, 8 publications between 2015 and 2020, average publication date December 2017. Japan, 15 publications between 2015 and 2020, average publication date June 2018. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, 4 publications between 2016 and 2020, average publication date July 2018. Paraparesis, Tropical Spastic, 3 publications between 2017 and 2020, average publication date October 2018. Familial Mediterranean Fever, 5 publications between 2018 and 2020, average publication date February 2019. Antibodies, Antineutrophil Cytoplasmic, 2 publications between 2017 and 2020, average publication date February 2019. Antigens, CD34, 5 publications between 2018 and 2020, average publication date March 2019. Human T-lymphotropic virus 1, 5 publications between 2017 and 2021, average publication date March 2019. Fibroblast Growth Factor 2, 2 publications between 2019 and 2020, average publication date September 2019. Complement C3, 2 publications between 2018 and 2021, average publication date March 2020.

To see the data from this visualization as text, click here.
Fukui's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (369)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.